Tag
The Health Policy law will require drug makers to disclose the amounts of free samples they distribute, a requirement which…

•
Wall Street Journal health blogger Katherine Hobson writes that, according to an investigation by Sen. Chuck Grassley, state chapters of…

•
Crikey.com, a news Web site based in Melbourne, Australia, calls our attention to some recent reporting about Mabthera, a drug…

•
Pharmaceutical companies are turning to doctors in private practice to promote their products as universities have developed conflict-of-interest policies that…

•
Health journalists may be surprised to find support from Paul Oestreicher, a marketing communications consultant and adjunct professor at New…

•
The Wall Street Journal‘s Jeanne Whalen writes that a recent string of charges against drug companies, including heavyweights like Pfizer,…

•
In a new report (pdf), the Government Accountability Office looks into what caused hundreds of extraordinary increases in prescription drug…

•
In a collaboration between The Philadelphia Inquirer and Kaiser Health News, Harris Meyer looks at the case of colchicine, a…

•
Under the headline “We want raw data, now,” BMJ editor Fiona Godlee recounts the story of how BMJ had to…

•
Prescription drug prices doubled from 1996 to 2006, according to new inflation-adjusted numbers from the Agency for Healthcare Research and…
